BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis (Q38170451)

30 August 2017

0 references

BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis (English)

1 reference

30 August 2017

1 reference

1 reference

Young Ho Lee

1 reference

30 August 2017

Gwan Gyu Song

series ordinal

1 reference

30 August 2017

language of work or name

1 reference

12 December 2013

1 reference

Journal of Motor Behavior

30 August 2017

published in

1 reference

30 August 2017

1 reference

30 August 2017

1 reference

30 August 2017

page(s)

59-66

1 reference

Exploration of genetic susceptibility factors for Parkinson's disease in a South American sample.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

The 712A/G polymorphism of Brain-derived neurotrophic factor is associated with Parkinson’s disease but not Major Depressive Disorder in a Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Lack of association between the BDNF Val66Met polymorphism and Parkinson's disease in a Swedish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Association between a polymorphism of brain-derived neurotrophic factor gene and sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson's disease in diverse ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00222895.2013.862199

10.1080/00222895.2013.862199

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference